Direkt zum Inhalt
Merck
  • Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.

Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.

Chest (1998-03-14)
P W Wong, N Macris, L DiFabrizio, N S Seriff
ZUSAMMENFASSUNG

A 69-year-old man with advanced prostate cancer was receiving antiandrogen therapy (bicalutamide [Casodex]). He developed dyspnea, peripheral eosinophilia and bilateral pulmonary interstitial infiltrates. Transbronchial biopsy confirmed pulmonary eosinophilia. Withdrawal of bicalutamide and initiation of steroid therapy resulted in clinical improvement.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Bicalutamid (CDX), ≥98% (HPLC), powder
Bicalutamid, European Pharmacopoeia (EP) Reference Standard
Bicalutamid für die Systemeignung, European Pharmacopoeia (EP) Reference Standard